Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T12:21:00.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-18T12:10:02.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T13:31:46.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now presents the complete study record with links to key PDFs and IPD sharing information, replacing the prior error and making the KEEPsAKE 2 details accessible.
    Difference
    100%
    Check dated 2026-09-27T19:43:17.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study record content, effectively blocking access to the NCT03671148 study details on ClinicalTrials.gov.
    Difference
    19%
    Check dated 2026-09-20T19:49:33.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added '2023 ( U.S. NIH Grant/Contract )' to the study identifiers. Updated the page revision from v3.6.5 to v3.6.6.
    Difference
    0.0%
    Check dated 2026-08-30T06:40:44.000Z thumbnail image

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.